Inspira Technologies Oxy B.H.N. Ltd (IINN)

$0.38 +0.01 (2.07%)
Market Cap 13.66M
Revenue (ttm) 290,000.00
Net Income (ttm) -13.22M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -4,558.62%
Debt to Equity Ratio 0.00
Volume 1,166,800
Avg Vol 357,966
Day's Range N/A - N/A
Shares Out 35.95M
Stochastic %K 19%
Beta 2.16
Analysts Strong Sell
Price Target $5.00

Company Profile

Inspira Technologies Oxy B.H.N. Ltd., a specialty medical device company, engages in the research, development, manufacturing, and marketing of proprietary life support technologies for the treatment of acute respiratory failure in Israel. It offers INSPIRA ART100, a life support system used in procedures requiring cardiopulmonary bypass for six hours or less. It also offers HYLA blood sensor, which is designed to perform real-time sampling and analysis of key blood parameter measurements. The c...

Industry: Medical Devices
Sector: Healthcare
Phone: 972 4 623 0333
Address:
2 Ha-Tidhar St., Ra'anana, Israel
Latest News on IINN
QTREX Announces Pricing of a $10 Million Registered Direct Offering of Ordinary Shares

Aug 20, 2026, 8:30 AM EDT - 7 days ago

QTREX Announces Pricing of a $10 Million Registered Direct Offering of Ordinary Shares

QTEX

QTREX's Patent-Pending Technology Achieves First Direct Conversion of 3D-Printed Insulation into Graphene-Like Carbon to Protect Quantum Processors

Aug 19, 2026, 9:09 AM EDT - 8 days ago

QTREX's Patent-Pending Technology Achieves First Direct Conversion of 3D-Printed Insulation into Graphene-Like Carbon to Protect Quantum Processors

QTEX

QTREX and U.S. Department of Defense Laboratory Target Q4 2026 to Formalize Joint Quantum Development Program

Aug 13, 2026, 8:00 AM EDT - 14 days ago

QTREX and U.S. Department of Defense Laboratory Target Q4 2026 to Formalize Joint Quantum Development Program

QTEX

QTREX Proprietary Quantum Interconnect Platform Exceeds Performance Requirements Established by Strategic Partners

Jul 31, 2026, 9:03 AM EDT - 27 days ago

QTREX Proprietary Quantum Interconnect Platform Exceeds Performance Requirements Established by Strategic Partners

QTEX

QTREX Launches Quantum Interconnect Research Program with Commercialization Rights to Project-Generated IP

Jul 27, 2026, 7:30 AM EDT - 4 weeks ago

QTREX Launches Quantum Interconnect Research Program with Commercialization Rights to Project-Generated IP

QTEX

QTREX Announces Clarification to Registration Statement on Form F-1

Jul 22, 2026, 12:40 PM EDT - 5 weeks ago

QTREX Announces Clarification to Registration Statement on Form F-1

QTEX

QTREX Appoints Dr. Shlomit Chappel-Ram, Veteran AME R&D Executive, as Independent Director

Jul 17, 2026, 8:30 AM EDT - 5 weeks ago

QTREX Appoints Dr. Shlomit Chappel-Ram, Veteran AME R&D Executive, as Independent Director

QTEX

QTREX Secures Commercial Order and Begins Production for Leading International Government-Owned Company

Jul 14, 2026, 9:00 AM EDT - 6 weeks ago

QTREX Secures Commercial Order and Begins Production for Leading International Government-Owned Company

QTEX

QTREX Establishes U.S. Subsidiary to Advance Federal Government Contracting

Jul 10, 2026, 7:30 AM EDT - 6 weeks ago

QTREX Establishes U.S. Subsidiary to Advance Federal Government Contracting

QTEX

QTREX Announces Operational AME System at U.S. Government Lab with a Quantum Computing Program focused on National Security

Jul 6, 2026, 8:20 AM EDT - 7 weeks ago

QTREX Announces Operational AME System at U.S. Government Lab with a Quantum Computing Program focused on National Security

QTEX

QTREX Engineers Conductivity Itself to Address Quantum Computing's Cryogenic Heat-Load Barrier

Jul 1, 2026, 8:40 AM EDT - 2 months ago

QTREX Engineers Conductivity Itself to Address Quantum Computing's Cryogenic Heat-Load Barrier

QTEX

QTREX Announces Management Share Purchase Plan

Jun 22, 2026, 7:00 AM EDT - 2 months ago

QTREX Announces Management Share Purchase Plan

QTEX

QTREX Expands into Quantum Processor Interface with Single-Build Cryogenic Chip Carrier

Jun 18, 2026, 7:30 AM EDT - 2 months ago

QTREX Expands into Quantum Processor Interface with Single-Build Cryogenic Chip Carrier

QTEX

QTREX Quantum's AME Technology Achieves 97% Yield Validation at One of the Largest U.S. Interconnect Manufacturers

Jun 15, 2026, 8:30 AM EDT - 2 months ago

QTREX Quantum's AME Technology Achieves 97% Yield Validation at One of the Largest U.S. Interconnect Manufacturers

QTEX

QTREX Awarded Government Grant to Advance the World's First Native RF Dielectric Material for Quantum Computing

Jun 9, 2026, 7:30 AM EDT - 2 months ago

QTREX Awarded Government Grant to Advance the World's First Native RF Dielectric Material for Quantum Computing

QTEX

QTREX to Showcase Functional AME-Based Monolithic Connectivity Components for Quantum Computing Systems at Quantum.Tech World 2026 in Boston

Jun 2, 2026, 7:30 AM EDT - 3 months ago

QTREX to Showcase Functional AME-Based Monolithic Connectivity Components for Quantum Computing Systems at Quantum.Tech World 2026 in Boston

QTEX

QTREX Secures Purchase Order from a U.S.-based Fortune 500 company for an AME System and Related Materials

Jun 1, 2026, 9:20 AM EDT - 3 months ago

QTREX Secures Purchase Order from a U.S.-based Fortune 500 company for an AME System and Related Materials

QTEX

QTREX Announces Pricing of a $10 Million Private Placement of Ordinary Shares with a New Fundamental Institutional Investor

May 29, 2026, 8:00 AM EDT - 3 months ago

QTREX Announces Pricing of a $10 Million Private Placement of Ordinary Shares with a New Fundamental Institutional Investor

QTEX

QTREX in Advanced Discussions with Top-Five Global Quantum Computing Company Regarding Strategic Collaboration

May 21, 2026, 8:00 AM EDT - 3 months ago

QTREX in Advanced Discussions with Top-Five Global Quantum Computing Company Regarding Strategic Collaboration

Inspira Technologies to Begin Trading as QTREX Quantum Under Nasdaq Ticker "QTEX" on May 20, 2026, Following Strategic Focus on AME and Quantum Connectivity

May 19, 2026, 8:00 AM EDT - 3 months ago

Inspira Technologies to Begin Trading as QTREX Quantum Under Nasdaq Ticker "QTEX" on May 20, 2026, Following Strategic Focus on AME and Quantum Connectivity

NYU Langone Issues $580,000 Purchase Order for Inspira's FDA-Cleared ART100 Following Multi-Patient Hospital Evaluation

May 18, 2026, 7:30 AM EDT - 3 months ago

NYU Langone Issues $580,000 Purchase Order for Inspira's FDA-Cleared ART100 Following Multi-Patient Hospital Evaluation

Inspira Technologies CEO Issues Letter to Shareholders on Strategic Direction and Value Creation Plan

May 11, 2026, 7:31 AM EDT - 3 months ago

Inspira Technologies CEO Issues Letter to Shareholders on Strategic Direction and Value Creation Plan

Inspira Secures $596,000 AME System Order from Leading Irish Technological University

May 1, 2026, 8:21 AM EDT - 4 months ago

Inspira Secures $596,000 AME System Order from Leading Irish Technological University

Inspira and Qarakal Sign Joint Development Agreement for Cryogenic Interconnects in Superconducting Quantum Systems

Apr 30, 2026, 8:01 AM EDT - 4 months ago

Inspira and Qarakal Sign Joint Development Agreement for Cryogenic Interconnects in Superconducting Quantum Systems

Inspira Technologies Secures Fully Paid $390,000 Purchase Order and Recurring Revenue Stream from Premier APAC University

Apr 28, 2026, 8:51 AM EDT - 4 months ago

Inspira Technologies Secures Fully Paid $390,000 Purchase Order and Recurring Revenue Stream from Premier APAC University

Inspira Completes Commercial Deployment of its AME System at a Tier-1 U.S. Defense Entity

Apr 16, 2026, 9:21 AM EDT - 4 months ago

Inspira Completes Commercial Deployment of its AME System at a Tier-1 U.S. Defense Entity

Inspira Technologies Appoints Yoav Rozanovich as Chief Business Officer to Drive Immediate Revenue Growth and Quantum Expansion

Apr 14, 2026, 8:01 AM EDT - 4 months ago

Inspira Technologies Appoints Yoav Rozanovich as Chief Business Officer to Drive Immediate Revenue Growth and Quantum Expansion

NNDM SSYS

Inspira Begins AME Technology Implementation Process with One of the World's 10 Largest U.S. Based Companies

Apr 13, 2026, 8:16 AM EDT - 4 months ago

Inspira Begins AME Technology Implementation Process with One of the World's 10 Largest U.S. Based Companies

Inspira Enters Quantum Computing Sector, Targeting a Critical Connectivity Bottleneck with Newly Acquired AME Platform

Apr 6, 2026, 9:01 AM EDT - 5 months ago

Inspira Enters Quantum Computing Sector, Targeting a Critical Connectivity Bottleneck with Newly Acquired AME Platform

Inspira Technologies Announces Acquisition of the AME Platform from Nano Dimension

Apr 6, 2026, 8:31 AM EDT - 5 months ago

Inspira Technologies Announces Acquisition of the AME Platform from Nano Dimension

Inspira Technologies Terminates ATM and SEPA Equity Facilities to Prepare for Next Strategic Phase

Mar 31, 2026, 8:16 AM EDT - 5 months ago

Inspira Technologies Terminates ATM and SEPA Equity Facilities to Prepare for Next Strategic Phase

Inspira Technologies Reports Full Year 2025 Financial Results and Provides Business Updates

Mar 26, 2026, 4:30 PM EDT - 5 months ago

Inspira Technologies Reports Full Year 2025 Financial Results and Provides Business Updates

Inspira Receives Nasdaq Notification Regarding Minimum Market Value Deficiency

Feb 25, 2026, 4:10 PM EST - 6 months ago

Inspira Receives Nasdaq Notification Regarding Minimum Market Value Deficiency

Inspira Expands U.S. Commercial Footprint: Deploys ART100 at a New Premier New York Academic Medical Center, Ranked Top 10 in New York State

Feb 18, 2026, 8:32 AM EST - 6 months ago

Inspira Expands U.S. Commercial Footprint: Deploys ART100 at a New Premier New York Academic Medical Center, Ranked Top 10 in New York State

Inspira Accelerates U.S. Commercial Strategy: FDA-Cleared ART100 Targets Market Adoption at AmSECT 2026 via Glo-Med Networks

Feb 17, 2026, 8:00 AM EST - 6 months ago

Inspira Accelerates U.S. Commercial Strategy: FDA-Cleared ART100 Targets Market Adoption at AmSECT 2026 via Glo-Med Networks

Inspira Technologies Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Requirement

Feb 12, 2026, 4:01 PM EST - 7 months ago

Inspira Technologies Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Requirement

Inspira Technologies Validates Next-Gen Standalone HYLA™ Blood Sensor with Clinical-Grade Accuracy, Targeting $48 Billion Heart-Lung Surgery Market

Feb 3, 2026, 9:22 AM EST - 7 months ago

Inspira Technologies Validates Next-Gen Standalone HYLA™ Blood Sensor with Clinical-Grade Accuracy, Targeting $48 Billion Heart-Lung Surgery Market

Inspira Advances to Final Governmental Budgetary Validation Procedures for Previously Announced Binding Purchase Orders

Jan 21, 2026, 8:50 AM EST - 7 months ago

Inspira Advances to Final Governmental Budgetary Validation Procedures for Previously Announced Binding Purchase Orders

CORRECTION – Inspira Signs Term Sheet for Acquisition of Advanced Liquid Biopsy Cancer Diagnostics Technology and Investment of $15 Million into Inspira at $180 Million Valuation

Jan 5, 2026, 10:46 AM EST - 8 months ago

CORRECTION – Inspira Signs Term Sheet for Acquisition of Advanced Liquid Biopsy Cancer Diagnostics Technology and Investment of $15 Million into Inspira at $180 Million Valuation

Inspira Signs Term Sheet for Acquisition of Advanced Liquid Biopsy Cancer Diagnostics Technology and Concurrent $15 Million Investment at $180 Million Valuation

Jan 5, 2026, 9:30 AM EST - 8 months ago

Inspira Signs Term Sheet for Acquisition of Advanced Liquid Biopsy Cancer Diagnostics Technology and Concurrent $15 Million Investment at $180 Million Valuation

Inspira Technologies Reaffirms $49.5 Million in Binding Purchase Orders and Aligns Execution with 2026 Regulatory and Deployment Milestones

Dec 23, 2025, 8:30 AM EST - 8 months ago

Inspira Technologies Reaffirms $49.5 Million in Binding Purchase Orders and Aligns Execution with 2026 Regulatory and Deployment Milestones

Inspira Announces $1.8 Million Registered Direct Offering Priced At-The-Market and Additional Equity Financing Agreement to Support Ongoing Commercial Execution

Dec 15, 2025, 8:30 AM EST - 9 months ago

Inspira Announces $1.8 Million Registered Direct Offering Priced At-The-Market and Additional Equity Financing Agreement to Support Ongoing Commercial Execution

Inspira Technologies Announces Strategic Leap in Lab Capabilities – Accelerating Next-Generation Diagnostics and Blood Technology

Dec 3, 2025, 8:43 AM EST - 9 months ago

Inspira Technologies Announces Strategic Leap in Lab Capabilities – Accelerating Next-Generation Diagnostics and Blood Technology

Inspira Completes Clinical Study for HYLA™ Blood Sensor - Ahead of Regulatory Submission

Nov 13, 2025, 9:00 AM EST - 10 months ago

Inspira Completes Clinical Study for HYLA™ Blood Sensor - Ahead of Regulatory Submission

Inspira Technologies Nears Final Regulatory Clearance for the ART100 in the UAE, Accelerating Gulf Region Expansion

Nov 6, 2025, 9:10 AM EST - 10 months ago

Inspira Technologies Nears Final Regulatory Clearance for the ART100 in the UAE, Accelerating Gulf Region Expansion

Inspira and Bites Form Strategic Alliance to Embed AI as a Core Standard Across Inspira's Global Ecosystem

Oct 22, 2025, 8:30 AM EDT - 11 months ago

Inspira and Bites Form Strategic Alliance to Embed AI as a Core Standard Across Inspira's Global Ecosystem

Inspira Appoints Former Johnson & Johnson Executive as VP of Global Sales and New Board Member from a Leading International Investment Firm

Oct 21, 2025, 9:05 AM EDT - 11 months ago

Inspira Appoints Former Johnson & Johnson Executive as VP of Global Sales and New Board Member from a Leading International Investment Firm

Inspira Technologies Reports First Half 2025 Financial Results and Issues Business Update

Oct 1, 2025, 8:00 AM EDT - 11 months ago

Inspira Technologies Reports First Half 2025 Financial Results and Issues Business Update

Inspira Announces 97.3% Accuracy Results for HYLA™ Blood Sensor, Advancing Toward FDA Submission for Clearance

Sep 11, 2025, 9:30 AM EDT - 1 year ago

Inspira Announces 97.3% Accuracy Results for HYLA™ Blood Sensor, Advancing Toward FDA Submission for Clearance

Inspira Receives U.S. Patent Approval for the ART500 Core Technology, Key Patent Positions the Company to Dominate $20 Billion Estimated Market

Aug 22, 2025, 8:45 AM EDT - 1 year ago

Inspira Receives U.S. Patent Approval for the ART500 Core Technology, Key Patent Positions the Company to Dominate $20 Billion Estimated Market